Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Paltusotine is a nonpeptide somatostatin receptor 2 (SST2) agonist.1 It selectively inhibits cAMP production in cells expressing SST2 over cells expressing SST1, SST3, SST4, or SST5 (EC50s = 25, >1,000, >1,000, >1,000, and >1,000 nM, respectively). In vivo, paltusotine (3, 10, and 30 mg/kg) reduces growth hormone release stimulated by growth hormone-releasing hormone (GHRH) in rats. It also reduces plasma levels of insulin-like growth factor 1 (IGF-1) in beagle dogs.
WARNING This product is not for human or veterinary use.
1. Discovery of paltusotine (CRN00808), a potent, selective, and orally bioavailable non-